Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as a sterile injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, severe pneumonia, sepsis and septic shock in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

- Complicated intra‑abdominal infections: effective for treating severe intra‑abdominal infections caused by susceptible organisms. - Complicated urinary tract infections: clears resistant Gram‑negative uropathogens in hospitalized patients. - Bacterial meningitis: achieves therapeutic concentrations in cerebrospinal fluid for meningitis caused by susceptible bacteria. - Severe community‑acquired or nosocomial pneumonia: provides coverage against multidrug‑resistant respiratory pathogens. - Sepsis and septic shock: rapid bactericidal activity helps control systemic infections in critical care settings.

Adverse reactions may occur with any antimicrobial therapy and should be monitored during treatment.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limited. - Rash: erythematous skin eruptions. - Headache: transient cranial discomfort. - Elevated liver enzymes: mild transaminase increases. - Injection‑site phlebitis: local irritation at IV site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile infection: severe colitis risk. - Anaphylaxis: acute hypersensitivity reaction. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals.

Use meropenem with caution and observe clinical monitoring for potential complications.

- Renal impairment: adjust dose based on creatinine clearance. - Hypersensitivity: discontinue if allergic reactions develop. - Pregnancy: only if clearly needed, as safety data are limited. - Seizure risk: avoid in patients with a history of epilepsy or CNS disorders. - Concomitant nephrotoxic drugs: monitor renal function closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: carbapenems can reduce valproate levels, risking seizure breakthrough. - Probenecid: may increase meropenem plasma concentrations, enhancing toxicity. - Carbapenem‑anticonvulsant interaction: increased seizure risk when combined with other seizure‑lowering agents.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: may exacerbate renal impairment. - NSAIDs: potential for reduced renal clearance; observe kidney markers.